110 related articles for article (PubMed ID: 20495415)
1. Translational emphasis: hypoxia and vasculogenesis in glioma recurrence.
Neman J; Jandial R
Neurosurgery; 2010 Jun; 66(6):N20-1. PubMed ID: 20495415
[No Abstract] [Full Text] [Related]
2. [Anti-angiogenesis treatment for brain tumors: present and future].
Takano S; Matsumura A
No Shinkei Geka; 2006 Jul; 34(7):657-78. PubMed ID: 16841703
[No Abstract] [Full Text] [Related]
3. Therapeutic options for recurrent malignant glioma.
Niyazi M; Siefert A; Schwarz SB; Ganswindt U; Kreth FW; Tonn JC; Belka C
Radiother Oncol; 2011 Jan; 98(1):1-14. PubMed ID: 21159396
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of growth of C6 glioma cells in vivo by expression of antisense vascular endothelial growth factor sequence.
Saleh M; Stacker SA; Wilks AF
Cancer Res; 1996 Jan; 56(2):393-401. PubMed ID: 8542597
[TBL] [Abstract][Full Text] [Related]
5. Tumor stromal-derived factor-1 recruits vascular progenitors to mitotic neovasculature, where microenvironment influences their differentiated phenotypes.
Aghi M; Cohen KS; Klein RJ; Scadden DT; Chiocca EA
Cancer Res; 2006 Sep; 66(18):9054-64. PubMed ID: 16982747
[TBL] [Abstract][Full Text] [Related]
6. Re: angiogenesis and antiangiogenic therapy for malignant gliomas.
Kepes JJ
Brain Tumor Pathol; 2005; 22(1):51. PubMed ID: 18095105
[No Abstract] [Full Text] [Related]
7. Plasminogen kringle 5-engineered glioma cells block migration of tumor-associated macrophages and suppress tumor vascularization and progression.
Perri SR; Nalbantoglu J; Annabi B; Koty Z; Lejeune L; François M; Di Falco MR; Béliveau R; Galipeau J
Cancer Res; 2005 Sep; 65(18):8359-65. PubMed ID: 16166313
[TBL] [Abstract][Full Text] [Related]
8. Angiogenesis and invasion in glioma.
Onishi M; Ichikawa T; Kurozumi K; Date I
Brain Tumor Pathol; 2011 Feb; 28(1):13-24. PubMed ID: 21221826
[TBL] [Abstract][Full Text] [Related]
9. Ask the Experts: How best to treat recurrent glioma.
Levin VA
CNS Oncol; 2012 Sep; 1(1):21-4. PubMed ID: 25054296
[TBL] [Abstract][Full Text] [Related]
10. Immunotherapy against angiogenesis-associated targets: evidence and implications for the treatment of malignant glioma.
Everson RG; Graner MW; Gromeier M; Vredenburgh JJ; Desjardins A; Reardon DA; Friedman HS; Friedman AH; Bigner DD; Sampson JH
Expert Rev Anticancer Ther; 2008 May; 8(5):717-32. PubMed ID: 18471045
[TBL] [Abstract][Full Text] [Related]
11. Endostatin "cell factories" shrink rodent brain tumors.
Brower V
Trends Mol Med; 2001 Mar; 7(3):97-8. PubMed ID: 11286765
[No Abstract] [Full Text] [Related]
12. Angiogenesis in malignant gliomas.
Plate KH; Risau W
Glia; 1995 Nov; 15(3):339-47. PubMed ID: 8586468
[TBL] [Abstract][Full Text] [Related]
13. Angiogenesis and anti-angiogenic molecularly targeted therapies in malignant gliomas.
Argyriou AA; Giannopoulou E; Kalofonos HP
Oncology; 2009; 77(1):1-11. PubMed ID: 19439998
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of angiogenesis and invasion in malignant gliomas.
Chi A; Norden AD; Wen PY
Expert Rev Anticancer Ther; 2007 Nov; 7(11):1537-60. PubMed ID: 18020923
[TBL] [Abstract][Full Text] [Related]
15. Expression of angiopoietin-2 in human glioma cells and its role for angiogenesis.
Koga K; Todaka T; Morioka M; Hamada J; Kai Y; Yano S; Okamura A; Takakura N; Suda T; Ushio Y
Cancer Res; 2001 Aug; 61(16):6248-54. PubMed ID: 11507079
[TBL] [Abstract][Full Text] [Related]
16. Endothelial progenitor cells' "homing" specificity to brain tumors.
Moore XL; Lu J; Sun L; Zhu CJ; Tan P; Wong MC
Gene Ther; 2004 May; 11(10):811-8. PubMed ID: 15057261
[TBL] [Abstract][Full Text] [Related]
17. Current perspectives on antiangiogenesis strategies in the treatment of malignant gliomas.
Jansen M; de Witt Hamer PC; Witmer AN; Troost D; van Noorden CJ
Brain Res Brain Res Rev; 2004 Jul; 45(3):143-63. PubMed ID: 15210301
[TBL] [Abstract][Full Text] [Related]
18. Tumor angiogenesis--a new therapeutic target in gliomas.
Lund EL; Spang-Thomsen M; Skovgaard-Poulsen H; Kristjansen PE
Acta Neurol Scand; 1998 Jan; 97(1):52-62. PubMed ID: 9482679
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of glioma-associated neovascularization.
Hardee ME; Zagzag D
Am J Pathol; 2012 Oct; 181(4):1126-41. PubMed ID: 22858156
[TBL] [Abstract][Full Text] [Related]
20. Proteomics-based analysis of a pair of glioma cell lines with different tumor forming characteristics.
Zhou L; Wang Y; Zhang YT; Geng YP; Si LS; Wang YL
Neurosci Lett; 2006 Jun; 401(1-2):59-64. PubMed ID: 16567038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
